Literature DB >> 3040166

Regional distribution of mu, delta and kappa opioid receptors in human brains from controls and parkinsonian subjects.

P Delay-Goyet, J M Zajac, F Javoy-Agid, Y Agid, B P Roques.   

Abstract

The binding properties of mu and delta opioid receptors were investigated in several areas of human brain by using [3H]Tyr-D-Ala-Gly-(Me)Phe-Gly-ol and [3H]Tyr-D-Thr-Gly-Phe-Leu-Thr as respective selective ligands, while the totality of opioid receptors was measured by using [3H]etorphine as a non-selective agonist. Receptor densities were highest in cerebral cortex, amygdala and striatum, and lowest in the substantia nigra (pars compacta). In the different brain areas of patients with Parkinson's disease, the density and the proportion of the various opioid receptors were not significantly different from control subjects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040166     DOI: 10.1016/0006-8993(87)91321-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Laminar distribution of the multiple opioid receptors in the human cerebral cortex.

Authors:  J M Hiller; L Q Fan
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

2.  Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.

Authors:  Mika Naganawa; Leslie K Jacobsen; Ming-Qiang Zheng; Shu-Fei Lin; Anindita Banerjee; Wonkyung Byon; David Weinzimmer; Giampaolo Tomasi; Nabeel Nabulsi; Sarah Grimwood; Lori L Badura; Richard E Carson; Timothy J McCarthy; Yiyun Huang
Journal:  Neuroimage       Date:  2014-05-17       Impact factor: 6.556

3.  Kinetic modeling of (11)C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humans.

Authors:  Mika Naganawa; Ming-Qiang Zheng; Nabeel Nabulsi; Giampaolo Tomasi; Shannan Henry; Shu-Fei Lin; Jim Ropchan; David Labaree; Johannes Tauscher; Alexander Neumeister; Richard E Carson; Yiyun Huang
Journal:  J Cereb Blood Flow Metab       Date:  2014-09-03       Impact factor: 6.200

Review 4.  The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.

Authors:  Martin L Dalefield; Brittany Scouller; Rabia Bibi; Bronwyn M Kivell
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

5.  Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140).

Authors:  Miguel Guerrero; Mariangela Urbano; Eun-Kyong Kim; Ana M Gamo; Sean Riley; Lusine Abgaryan; Nora Leaf; Lori Jean Van Orden; Steven J Brown; Jennifer Y Xie; Frank Porreca; Michael D Cameron; Hugh Rosen; Edward Roberts
Journal:  J Med Chem       Date:  2019-02-13       Impact factor: 7.446

6.  Determination of the in vivo selectivity of a new κ-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey.

Authors:  Su Jin Kim; Ming-Qiang Zheng; Nabeel Nabulsi; David Labaree; Jim Ropchan; Soheila Najafzadeh; Richard E Carson; Yiyun Huang; Evan D Morris
Journal:  J Nucl Med       Date:  2013-08-05       Impact factor: 10.057

7.  Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeys.

Authors:  R J Vermeulen; B Drukarch; M C Sahadat; C Goosen; A N Schoffelmeer; E C Wolters; J C Stoof
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

Review 8.  Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches.

Authors:  Marta Peciña; Jordan F Karp; Sanjay Mathew; Mark S Todtenkopf; Elliot W Ehrich; Jon-Kar Zubieta
Journal:  Mol Psychiatry       Date:  2018-06-28       Impact factor: 15.992

Review 9.  Emotionality vs. Other Biobehavioural Traits: A Look at Neurochemical Biomarkers for Their Differentiation.

Authors:  Irina N Trofimova; Anastasia A Gaykalova
Journal:  Front Psychol       Date:  2021-12-20

10.  Opioid antagonism modulates wanting-related frontostriatal connectivity.

Authors:  Alexander Soutschek; Susanna C Weber; Thorsten Kahnt; Boris B Quednow; Philippe N Tobler
Journal:  Elife       Date:  2021-11-11       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.